Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey-Reference-Cited by-同舟云学术

Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey

Published:2020-03-19 Issue:1 Volume:6 Page:93-105
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Lancaster Lisa H.,Valenzuela Claudia,Mason Wendi,Neurohr Claus,Ripamonti Elena,Kirchgaessler Klaus-Uwe,Cottin Vincent^ORCID

Funder

F. Hoffmann-La Roche, Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

http://link.springer.com/content/pdf/10.1007/s41030-020-00111-y.pdf

Reference25 articles.

1. Kreuter M. Pirfenidone: an update on clinical trial data and insights from everyday practice. Eur Respir Rev. 2014;23:111–7.

2. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431–40.

3. Duck A, Spencer LG, Bailey S, Leonard C, Ormes J, Caress AL. Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs. 2015;71:1055–65.

4. van Manen MJ, Geelhoed JJ, Tak NC, Wijsenbeek MS. Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2017;11:157–69.

5. Bonella F, Wijsenbeek M, Molina-Molina M, et al. European IPF patient charter: unmet needs and a call to action for healthcare policymakers. Eur Respir J. 2016;47:597–606.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort;Advances in Therapy;2021-11-10